Home > Categories > Healthcare > Diagnosis > IBM Watson for Oncology

IBM Watson for Oncology

Rating:

4.5 / 5.0

Tags

Healthcare AI, Medical AI, Oncology, Decision Support, IBM Watson, AI in Medicine, Clinical Support

Categories:
Business AnalyticsHealthcareScientific Research
Creator IBM Watson Health
Date 2014-01-01
Platforms Cloud Platform, healthcare systems
Status Active
Website ibm.com
Price Model Subscription
Sections:
Decision SupportDiagnosisScientific Data Analysis

Pricing Details

Provided on a subscription basis for healthcare institutions. Pricing depends on the scale of implementation and the number of users.

Features

Analysis of medical literature, clinical guidelines, patient data analysis, treatment option recommendations, evidence-based support, integration with clinical workflows.

Integrations

Integration with Electronic Health Record (EHR) systems for patient data access.

Preview

IBM Watson for Oncology is a cognitive computing system developed by IBM Watson Health in collaboration with Memorial Sloan Kettering Cancer Center. It is designed to assist oncologists in selecting optimal cancer treatment options based on analyzing vast amounts of data, including medical literature (journals, textbooks), clinical trials, drug information, and clinical guidelines. The system analyzes specific patient characteristics and compares them against its knowledge base, providing physicians with a list of potential treatment options supported by evidence. It is important to note that Watson for Oncology is a decision support tool and does not replace a physician's clinical judgment.